UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: Article | Book | Book chapter | Proceedings paper | Report
Number of items: 94.

Article

Antonow, D and Kaliszczak, M and Kang, GD and Coffils, M and Tiberghien, AC and Cooper, N and Barata, T and Heidelberger, S and James, CH and Zloh, M and Jenkins, TC and Reszka, AP and Neidle, S and Guichard, SM and Jodrell, DI and Hartley, JA and Howard, PW and Thurston, DE (2010) Structure-Activity Relationships of Monomeric C2-Aryl Pyrrolo[2,1-c][1,4]benzodiazepine (PBD) Antitumor Agents. J MED CHEM , 53 (7) 2927 - 2941. 10.1021/jm901722v.

Bockenhauer, D and Reichold, M and Zdebik, A and Lieberer, E and Schmidt, K and Rapedius, M and Bandulik, S and Sterner, C and Tegtmeier, I and Baukrowitz, T and Hulton, SA and Ben-Zeev, B and Howie, AJ and Warth, R and Kleta, R (2010) Altered Renal Tubular Ultrastructure and Electrophysiology Caused by KCNJ10 Mutations in EAST Syndrome. PEDIATR NEPHROL , 25 (9) 1980 - 1980.

Boss, DS and Schwartz, GK and Middleton, MR and Amakye, DD and Swaisland, H and Midgley, RS and Ranson, M and Danson, S and Calvert, H and Plummer, R and Morris, C and Carvajal, RD and Chirieac, LR and Schellens, JHM and Shapiro, GI (2010) Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours. ANN ONCOL , 21 (4) 884 - 894. 10.1093/annonc/mdp377.

Brada, M and Stenning, S and Gabe, R and Thompson, LC and Levy, D and Rampling, R and Erridge, S and Saran, F and Gattamaneni, R and Hopkins, K and Beall, S and Collins, VP and Lee, SM (2010) Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma. JOURNAL OF CLINICAL ONCOLOGY , 28 (30) 4601 - 4608. 10.1200/JCO.2009.27.1932.

Bridgewater, J and Wasan, H and Valle, J (2010) Cisplatin plus Gemcitabine for Biliary Tract Cancer REPLY. NEW ENGLAND JOURNAL OF MEDICINE , 363 (2) 192 - 193.

Brunetto, AT and Ang, JE and Olmos, D and Tan, D and Barriuso, J and Arkenau, HT and Yap, TA and Molife, LR and Banerji, U and de Bono, J and Judson, I and Kaye, S (2010) A study of the pattern of hospital admissions in a specialist Phase I oncology trials unit: unplanned admissions as an early indicator of patient attrition. Eur J Cancer , 46 (15) 2739 - 2745. 10.1016/j.ejca.2010.06.123.

Brunetto, AT and Kristeleit, RS and De Bono, JS (2010) Early oncology clinical trial design in the era of molecular-targeted agents. Future Oncology , 6 (8) 1339 - 1352.

Chavda, S and Babu, B and Yanow, SK and Jardim, A and Spithill, TW and Kiakos, K and Kluza, J and Hartley, JA and Lee, M (2010) A novel achiral seco-cyclopropylpyrido[e]indolone (CPyI) analog of CC-1065 and the duocarmycins: Synthesis, DNA interactions, in vivo anticancer and anti-parasitic evaluation. BIOORGAN MED CHEM , 18 (14) 5016 - 5024. 10.1016/j.bmc.2010.05.078.

Chavda, S and Mulder, K and Brown, T and Mackay, H and Babu, B and Westrate, L and Ferguson, A and Lin, SC and Kiakos, K and Ramos, JP and Munde, M and Wilson, WD and Hartley, JA and Lee, M (2010) DNA Recognition: Design, Synthesis and Biophysical Characteristics of Pyrrole(H) Based Polyamides. MED CHEM , 6 (3) 150 - 158.

Dick, J and Begent, RH and Meyer, T (2010) Sarcoidosis and testicular cancer: A case series and literature review. UROL ONCOL-SEMIN ORI , 28 (4) 350 - 354. 10.1016/j.urolonc.2008.09.029.

Fern, LA and Whelan, JS (2010) Recruitment of adolescents and young adults to cancer clinical trials--international comparisons, barriers, and implications. Semin Oncol , 37 (2) e1 - e8. 10.1053/j.seminoncol.2010.04.002.

Fischer, U and Leidinger, P and Keller, A and Folarin, A and Keller, R and Graf, N and Lenhof, HP and Meese, E (2010) Amplicons on chromosome 12q13-21 in glioblastoma recurrences. INT J CANCER , 126 (11) 2594 - 2602. 10.1002/ijc.24971.

Fish, R and Pinney, J and Jain, P and Addison, C and Jones, C and Jayawardene, S and Booth, J and Howie, AJ and Ghonemy, T and Rajabali, S and Roberts, D and White, L and Khan, S and Morgan, M and Cockwell, P and Hutchison, CA (2010) The Incidence of Major Hemorrhagic Complications After Renal Biopsies in Patients with Monoclonal Gammopathies. CLIN J AM SOC NEPHRO , 5 (11) 1977 - 1980.

Fogo, AB and Bostad, L and Svarstad, E and Cook, WJ and Moll, S and Barbey, F and Geldenhuys, L and West, M and Ferluga, D and Vujkovac, B and Howie, AJ and Burns, A and Reeve, R and Waldek, S and Noel, L-H and Gruenfeld, J-P and Valbuena, C and Oliveira, JP and Mueller, J and Breunig, F and Zhang, X and Warnock, DG and ISGFN, (2010) Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). NEPHROLOGY DIALYSIS TRANSPLANTATION , 25 (7) 2168 - 2177. 10.1093/ndt/gfp528.

Folarin, AA and Konerding, MA and Timonen, J and Nagl, S and Pedley, RB (2010) Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomography. MICROVASC RES , 80 (1) 89 - 98. 10.1016/j.mvr.2010.03.007.

Forster, MD and Enting, D and Nicholson, AG and O'Brien, M and Popat, S (2010) The Combination of Young’s Syndrome and Small Cell Lung Cancer – A Spiky Connection? Lung Cancer , 67 (3) 372 - 375.

Forster, MD and Saijo, N and Seymour, L and Calvert, H (2010) Performing Phase I Clinical Trials of Anticancer Agents: Perspectives from within the European Union and Japan. CLIN CANCER RES , 16 (6) 1737 - 1744. 10.1158/1078-0432.CCR-09-2228.

Fox, J and Glasspool, D and Patkar, V and Austin, M and Black, L and South, M and Robertson, D and Vincent, C (2010) Delivering clinical decision support services: There is nothing as practical as a good theory. J BIOMED INFORM , 43 (5) 831 - 843. 10.1016/j.jbi.2010.06.002.

Franks, A and Tronrud, C and Kiakos, K and Kluza, J and Munde, M and Brown, T and Mackay, H and Wilson, WD and Hochhauser, D and Hartley, JA and Lee, M (2010) Targeting the ICB2 site of the topoisomerase II alpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamide. BIOORGAN MED CHEM , 18 (15) 5553 - 5561. 10.1016/j.bmc.2010.06.041.

Germani, G and Pleguezuelo, M and Gurusamy, K and Meyer, T and Isgro, G and Burroughs, AK (2010) Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. J HEPATOL , 52 (3) 380 - 388.

Giampieri, S and Pinner, S and Sahai, E (2010) Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Cancer Res , 70 (9) 3435 - 3439. 10.1158/0008-5472.CAN-10-0466.

Gillmore, R and Laurence, V and Raouf, S and Tobias, J and Blackman, G and Meyer, T and Goodchild, K and Collis, C and Bridgewater, J (2010) Chemoradiotherapy with or without Induction Chemotherapy for Locally Advanced Pancreatic Cancer: a UK Multi-institutional Experience. CLIN ONCOL-UK , 22 (7) 564 - 569. 10.1016/j.clon.2010.05.007.

Greimel, E and Nordin, AJ (2010) Application of quality-of-life measurements in clinical trials and in clinical practice for gynecologic cancer patients. Expert Review of Pharmacoeconomics and Outcomes Research , 10 (1) 63 - 71.

Hartley, JA and Hamaguchi, A and Coffils, M and Martin, CRH and Suggitt, M and Chen, ZZ and Gregson, SJ and Masterson, LA and Tiberghien, AC and Hartley, JM and Pepper, C and Lin, TT and Fegan, C and Thurston, DE and Howard, PW (2010) SG2285, a Novel C2-Aryl-Substituted Pyrrolobenzodiazepine Dimer Prodrug That Cross-links DNA and Exerts Highly Potent Antitumor Activity. CANCER RES , 70 (17) 6849 - 6858. 10.1158/0008-5472.CAN-10-0790.

Holme, H and Nanduri, V (2010) Paediatric presentation of familial cerebral cavernoma. Pediatr Blood Cancer , 54 (3) 468 - 469. 10.1002/pbc.22288.

Howie, AJ and Owen-Casey, MP (2010) Discrepancies between descriptions and illustrations of colours in Congo red-stained amyloid, and explanation of discrepant colours. Amyloid , 17 (3-4) 109 - 117. 10.3109/13506129.2010.527448.

Hua, J and Spee, C and Kase, S and Rennel, ES and Magnussen, AL and Qiu, Y and Varey, A and Dhayade, S and Churchill, AJ and Harper, SJ and Bates, DO and Hinton, DR (2010) Recombinant Human VEGF(165)b Inhibits Experimental Choroidal Neovascularization. INVEST OPHTH VIS SCI , 51 (8) 4282 - 4288. 10.1167/iovs.09-4360.

Juul, N and Szallasi, Z and Eklund, AC and Li, Q and Burrell, RA and Gerlinger, M and Valero, V and Andreopoulou, E and Esteva, FJ and Symmans, WF and Desmedt, C and Haibe-Kains, B and Sotiriou, C and Pusztai, L and Swanton, C (2010) Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol , 11 (4) 358 - 365. 10.1016/S1470-2045(10)70018-8.

Kiakos, K and Hartley, JM and Hartley, JA (2010) Measurement of DNA interstrand crosslinking in naked DNA using gel-based methods. Methods Mol Biol , 613 283 - 302. 10.1007/978-1-60327-418-0_18.

Ledermann, JA and Gabra, H and Jayson, GC and Spanswick, VJ and Rustin, GJS and Jitlal, M and James, LE and Hartley, JA (2010) Inhibition of Carboplatin-Induced DNA Interstrand Cross-link Repair by Gemcitabine in Patients Receiving these Drugs for Platinum-Resistant Ovarian Cancer. CLIN CANCER RES , 16 (19) 4899 - 4905. 10.1158/1078-0432.CCR-10-0832.

Ledermann, JA and Kristeleit, RS (2010) Optimal treatment for relapsing ovarian cancer. ANN ONCOL , 21 218 - 222. 10.1093/annonc/mdq377.

Lee, SM (2010) First-line maintenance (1LM) treatment: a new strategy to treat advanced NSCLC. Oncology News , 4 (6) 88 - 91.

Lee, SM and Baas, P and Wakelee, H (2010) Anti-angiogenesis drugs in lung cancer. Respirology , 15 (3) 387 - 392. 10.1111/j.1440-1843.2010.01715.x.

Lee, SM and Bass, P and Wakelee, H (2010) Anti-angiogenesis drugs in lung cancer. Respirology 387 - 392.

Magnussen, AL and Rennel, ES and Hua, J and Bevan, HS and Long, NB and Lehrling, C and Gammons, M and Floege, J and Harper, SJ and Agostini, HT and Bates, DO and Churchill, AJ (2010) VEGF-A(165)b Is Cytoprotective and Antiangiogenic in the Retina. INVEST OPHTH VIS SCI , 51 (8) 4273 - 4281. 10.1167/iovs.09-4296.

Mattila, K and Hyvaluoma, J and Folarin, AA and Rossi, T (2010) A boundary condition for arbitrary shaped inlets in lattice-Boltzmann simulations. INT J NUMER METH FL , 63 (5) 638 - 650. 10.1002/fld.2101.

Meyer, T and Caplin, ME and Palmer, DH and Valle, JW and Larvin, M and Waters, JS and Coxon, F and Borbath, I and Peeters, M and Nagano, E and Kato, H (2010) A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer. EUR J CANCER , 46 (3) 526 - 533. 10.1016/j.ejca.2009.11.004.

Middleton, MR and Knox, R and Cattell, E and Oppermann, U and Midgley, R and Ali, R and Auton, T and Agarwal, R and Anderson, D and Sarker, D and Judson, I and Osawa, T and Spanswick, VJ and Davies, S and Hartley, JA and Kerr, DJ (2010) Quinone Oxidoreductase-2-Mediated Prodrug Cancer Therapy. SCI TRANSL MED , 2 (40) , Article 40ra50. 10.1126/scitranslmed.3000615.

Molife, LR and Fong, PC and Paccagnella, L and Reid, AH and Shaw, HM and Vidal, L and Arkenau, HT and Karavasilis, V and Yap, TA and Olmos, D and Spicer, J and Postel-Vinay, S and Yin, D and Lipton, A and Demers, L and Leitzel, K and Gualberto, A and de Bono, JS (2010) The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study. Br J Cancer , 103 (3) 332 - 339. 10.1038/sj.bjc.6605767.

Munding, J and Baraniskin, A and Meier, D and Porschen, R and Arkenau, H and Graeven, U and Schulmann, K and Schmiegel, W and Tannapfel, A and Reinacher-Schick, A (2010) Value of SMAD4 in patients with advanced colorectal cancer (aCRC) receiving an oxaliplatin containing first line chemotherapy - a study of the AIO colorectal cancer group (AIO). ONKOLOGIE , 33 71 - 72.

Nutt, JE and Razak, ARA and O'Toole, K and Black, F and Quinn, AE and Calvert, AH and Plummer, ER and Lunec, J (2010) The role of folate receptor alpha (FR alpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy. BRIT J CANCER , 102 (3) 553 - 560. 10.1038/sj.bjc.6605501.

Orikawa, Y and Kato, H and Seto, K and Kobayashi, N and Yoshinaga, K and Hamano, H and Hori, Y and Meyer, T and Takei, M (2010) Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 beta production in a cancer-induced pain model in mice. MOL PAIN , 6 , Article 72. 10.1186/1744-8069-6-72.
An open access publication

Patterson, DM and Lee, SM (2010) Glucarpidase following high-dose methotrexate: update on development. Expert Opin Biol Ther , 10 (1) 105 - 111. 10.1517/14712590903468677.

Reichold, M and Zdebik, AA and Lieberer, E and Rapedius, M and Schmidt, K and Bandulik, S and Sterner, C and Tegtmeier, I and Penton, D and Baukrowitz, T and Hulton, SA and Witzgall, R and Ben-Zeev, B and Howie, AJ and Kleta, R and Bockenhauer, D and Warth, R (2010) KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. P NATL ACAD SCI USA , 107 (32) 14490 - 14495. 10.1073/pnas.1003072107.

Ringland, CL and Arkenau, HT and O'Connell, DL and Ward, RL (2010) Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry. Ann Oncol , 21 (1) 92 - 97. 10.1093/annonc/mdp288.

Rodriguez-Acebes, S and Proctor, I and Loddo, M and Wollenschlaeger, A and Rashid, M and Falzon, M and Prevost, AT and Sainsbury, R and Stoeber, K and Williams, GH (2010) Targeting DNA Replication before it Starts Cdc7 as a Therapeutic Target in p53-Mutant Breast Cancers. AM J PATHOL , 177 (4) 2034 - 2045. 10.2353/ajpath.2010.100421.

Shamash, J and Stebbing, J and Sweeney, C and Sonpavde, G and Harland, S and Dawkins, G and Brock, C and Abelman, W and Wilson, P and Sanitt, A and Oliver, T and Powles, T (2010) A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancer. Cancer , 116 (15) 3595 - 3602. 10.1002/cncr.25194.

Spanswick, VJ and Hartley, JM and Hartley, JA (2010) Measurement of DNA interstrand crosslinking in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 613 267 - 282. 10.1007/978-1-60327-418-0_17.

Srirajaskanthan, R and Caplin, ME and Waugh, MG and Watkins, J and Meyer, T and Hsuan, JJ and Beaumont, NJ (2010) Identification of Mac-2-binding Protein as a Putative Marker of Neuroendocrine Tumors from the Analysis of Cell Line Secretomes. MOL CELL PROTEOMICS , 9 (4) 656 - 666. 10.1074/mcp.M900401-MCP200.

Strauss, SJ and Ng, T and Mendoza-Naranjo, A and Whelan, J and Sorensen, PHB (2010) Understanding Micrometastatic Disease and Anoikis Resistance in Ewing Family of Tumors and Osteosarcoma. ONCOLOGIST , 15 (6) 627 - 635. 10.1634/theoncologist.2010-0093.

Taylor, RM and Franck, LS and Dhawan, A and Gibson, F (2010) The Stories of Young People Living With a Liver Transplant. QUAL HEALTH RES , 20 (8) 1076 - 1090. 10.1177/1049732310368405.

Taylor, RM and Wray, J and Gibson, F (2010) Measuring quality of life in children and young people after transplantation: Methodological considerations. PEDIATR TRANSPLANT , 14 (4) 445 - 458. 10.1111/j.1399-3046.2010.01316.x.

Theodoraki, A and Khoo, B and Hamda, A and Grillo, F and Meyer, T and Bouloux, PM (2010) Malignant somatostatinoma presenting with diabetic ketoacidosis and inhibitory syndrome: pathophysiologic considerations. Endocr.Pract. 1 - 12. 10.4158/EP10109.CR.

Tsochatzis, E and Meyer, T and Marelli, L and Burroughs, AK (2010) Which transarterial therapy is best for hepatocellular carcinoma? - The evidence to date. J HEPATOL , 53 (3) 588 - 588.

Turner, NC and Strauss, SJ and Sarker, D and Gillmore, R and Kirkwood, A and Hackshaw, A and Papadopoulou, A and Bell, J and Kayani, I and Toumpanakis, C and Grillo, F and Mayer, A and Hochhauser, D and Begent, RH and Caplin, ME and Meyer, T (2010) Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. BRIT J CANCER , 102 (7) 1106 - 1112. 10.1038/sj.bjc.6605618.

Valle, J and Wasan, H and Palmer, DH and Cunningham, D and Anthoney, A and Maraveyas, A and Madhusudan, S and Iveson, T and Hughes, S and Pereira, SP and Roughton, M and Bridgewater, J and ABC-02 Trial Investigators, (2010) Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer. NEW ENGL J MED , 362 (14) 1273 - 1281.

Vassileva, V (2010) Screening: IL-12 polymorphism linked to cervical cancer risk. Nature Reviews Clinical Oncology , 7 (1) 6 - 6.

Vassileva, V (2010) SRAP-new prognostic marker. Nature Reviews Clinical Oncology , 7 (1) 4 - 4.

Vassileva, V (2010) Targeted therapies: Farletuzumab-promising new agent in ovarian cancer. Nature Reviews Clinical Oncology , 7 (1) 5 - 5.

Vassileva, V and Piquette-Miller, M (2010) Inflammation: Extinguishing the Fires Within. CLIN PHARMACOL THER , 87 (4) 375 - 379. 10.1038/clpt.2010.10.

Vigor, KL and Kyrtatos, PG and Minogue, S and Al-Jamal, KT and Kogelberg, H and Tolner, B and Kostarelos, K and Begent, RH and Pankhurst, QA and Lythgoe, MF and Chester, KA (2010) Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells. BIOMATERIALS , 31 (6) 1307 - 1315. 10.1016/j.biomaterials.2009.10.036.

Whelan, JS and Casali, P and Blay, JS (2010) Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO/CONTICANET/EUROBONET Consensus Panel of experts. Ann Oncol , Suppl 5 198 - 203.

Whelan, JS and Casali, PG and Blay, JY (2010) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO/CONTICANET/EUROBONET Consensus Panel of Experts. Ann Oncol , Suppl 5 98 - 102.

Whelan, JS and Grimer, R and Athansou, N and Gerrand, C and Judson, I and Lewis, I and Morland, B and Peake, D and Seddon, B (2010) UK guidelines for the management of bone sarcomas. Sarcoma 2010:317462. Epub

Whelan, JS and Hogendoorn, PC and Athanasou, N and Bielack, S and De Alava, E and Tos, AP and Ferrari, S and Gelderblom, H and Grimer, R and Hall, KS and Hassan, B and Vanel, D (2010) Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol , Suppl 5 204 - 213.

Whelan, JS and Ladenstein, R and Potschger, U and Le Deley, M-C and Paulussen, M and Oberlin, O and van der Berg, H and Dirksen, L and Hjorth, L and Michon, J and Lewis, I and Craft, A and Jurgens, H (2010) Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial. J Clin Oncol , 10 (28) 3284 - 3291.

Yap, TA and Vidal, L and Adam, J and Stephens, P and Spicer, J and Shaw, H and Ang, J and Temple, G and Bell, S and Shahidi, M and Uttenreuther-Fischer, M and Stopfer, P and Futreal, A and Calvert, H and de Bono, JS and Plummer, R (2010) Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors. J CLIN ONCOL , 28 (25) 3965 - 3972. 10.1200/JCO.2009.26.7278.

Yogev, O and Goldberg, R and Anzi, S and Yogev, O and Shaulian, E (2010) Jun Proteins Are Starvation-Regulated Inhibitors of Autophagy. CANCER RES , 70 (6) 2318 - 2327. 10.1158/0008-5472.CAN-09-3408.

Yogev, O and Yogev, O and Singer, E and Shaulian, E and Goldberg, M and Fox, TD and Pines, O (2010) Fumarase: A Mitochondrial Metabolic Enzyme and a Cytosolic/Nuclear Component of the DNA Damage Response. PLOS BIOL , 8 (3) , Article e1000328. 10.1371/journal.pbio.1000328.
An open access publication

Yong, M and Begent, R (2010) Best use of experimental data in cancer informatics. Future Oncol , 6 (10) 1551 - 1562. 10.2217/fon.10.108.

Book

Meyer, T (2010) Vascular Disruptive Agents for the Treatment of Cancer. Not Avail

Tobias, J and Hochhauser, D (2010) Cancer and Its Management. Wiley-Blackwell

Book chapter

Arkenau, H (2010) Principles of Anticancer Drug Development. In: Garrett-Mayer, E, (ed.) Principles of Anticancer Drug Development. (? - ?). Springer Verlag

PEDLEY, R and Sharma, SK (2010) Xenograft Mouse Models for Tumour Targeting. In: Kontermann, R, (ed.) Antibody Engineering. (? - ?). Springer Verlag

Pedley, RB and tozer, G (2010) Vascular Disruptive Agents for the Treatment of Cancer. In: Meyer, T, (ed.) Vascular Disruptive Agents for the Treatment of Cancer. (49 - 75). Springer Verlag

Scatchard, K and Lee, SM (2010) Neurotoxicity of chemotherapy. In: Neuro-Oncology: Blue Books of Neurology Series. (352 - 371). Elsevier

Proceedings paper

Acosta, D and Patkar, V and Keshtgar, M and Fox, J (2010) Challenges in Delivering Decision Support Systems: The MATE Experience. In: Riano, D and TenTeije, A and Miksch, S and Peleg, M, (eds.) KNOWLEDGE REPRESENTATION FOR HEALTH-CARE: DATA, PROCESSES AND GUIDELINES. (pp. 124 - 140). SPRINGER-VERLAG BERLIN

Brucoli, F and Hawkins, RM and Wells, G and Jenkins, TC and Ellis, T and Kotecha, M and Hochhauser, D and Hartley, JA and Howard, PW and Thurston, DE (2010) A potent PBD-heterocyclic polyamide conjugate targeting an ICB2 transcription factor binding site. In: EJC SUPPLEMENTS. (pp. 168 - 168). PERGAMON-ELSEVIER SCIENCE LTD

Calvert, AH (2010) PARP INHIBITORS IN CLINICAL DEVELOPMENT - AN OVERVIEW. In: ANNALS OF ONCOLOGY. (pp. 17 - 17). OXFORD UNIV PRESS

Cox, ST and Stephens, HA and Fernando, R and Harber, M and Howie, A and Powis, S and Zou, YH and Stastny, P and Madrigal, JA and Little, AM (2010) MICA allele mismatching, MICA antibodies and rejection in renal transplantation. In: TISSUE ANTIGENS. (pp. 481 - 481). WILEY-BLACKWELL PUBLISHING, INC

Khan, M and Tsigani, T and Rashid, M and Luong, TV and Caplin, M and Meyer, T (2010) EpCam Expression and Detection of Circulating Tumor Cells in Neuroendocrine Tumors. In: NEUROENDOCRINOLOGY. (pp. 38 - 38). KARGER

Liccardi, G and Hartley, JA and Hochhauser, D (2010) EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. In: EJC SUPPLEMENTS. (pp. 166 - 166). PERGAMON-ELSEVIER SCIENCE LTD

Mahendran, AO and Papakrivopolou, J and Haroon, S and Dupont, PJ and Howie, AJ and Veitch, PS (2010) The Troubled Transplant: Can Early Surveillance Biopsy Predict the "At Risk Graft?". In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 437 - 438).

Mellinas-Gomez, M and Spanswick, VJ and Stell, A and Hartley, JA and Thurston, DE and Baines, S (2010) Investigation of the effect of the sequence-selective DNA cross-linking agent SJG-136 on canine tumour cells in vitro. In: EJC SUPPLEMENTS. (pp. 91 - 91). PERGAMON-ELSEVIER SCIENCE LTD

Meyer, T and Roughton, M and Yu, D and Davies, N and Williams, E and Pereira, S and Hochhauser, D and O'Beirne, J and Patch, D and Burroughs, AK (2010) A randomized phase II/III trial of three weekly cisplatin based transarterial chemoembolization (TACE) versus embolization (TAE) alone for hepatocellular cancer (HCC). In: Journal of Clinical Oncology. (pp. 4025 - ?).

Oliveira, JP and Fogo, AB and Bostad, L and Svarstad, E and Cook, WJ and Moll, S and Barbey, F and Geldenhuys, L and West, M and Ferluga, D and Vujkovac, B and Howie, AJ and Burns, A and Reeve, R and Waldek, S and Noel, L-H and Gruenfeld, J-P and Valbuena, C and Mueller, J and Breunig, F and Zhang, X and Warnock, DG and ISGFN, (2010) SCORING SYSTEM FOR RENAL PATHOLOGY IN FABRY DISEASE: REPORT OF THE INTERNATIONAL STUDY GROUP OF FABRY NEPHROPATHY (ISGFN). In: CLINICAL THERAPEUTICS. (pp. S105 - S105).

Patkar, V and Acosta, D and Fox, J and Jones, A and Davidson, T and Keshtgar, M (2010) A novel support tool for Breast Multidisciplinary Meetings: an advanced evidence based computer decision support technology. In: EJC SUPPLEMENTS. (pp. 211 - 211). PERGAMON-ELSEVIER SCIENCE LTD

Patkar, V and Acosta, D and Naughton, P and Fox, J and Jones, A and Keshtgar, M (2010) An advanced computerised decision support system for breast cancer multidisciplinary meetings: results of an audit study. In: BRITISH JOURNAL OF SURGERY. (pp. 42 - 42). JOHN WILEY & SONS LTD

Razak, AA and Nutt, J and O'Toole, K and Black, F and Cole, M and Plummer, R and Lunec, J and Calvert, H (2010) Expression of methylthioadenosine phosphorylase (MTAP) in malignant pleural mesothelioma (MPM) and its implication for pemetrexed-based chemotherapy. In: EJC SUPPLEMENTS. (pp. 173 - 173). PERGAMON-ELSEVIER SCIENCE LTD

Silini, A and Chiorino, G and Ghilardi, C and Dahse, R and Pedley, RB and Giavazzi, R and Bani, MR (2010) Differences in the stroma of human ovarian carcinoma xenografts endowed with different angiogenic phenotypes. In: EJC SUPPLEMENTS. (pp. 94 - 95). PERGAMON-ELSEVIER SCIENCE LTD

Thirlwell, C and Eymard, M and Meyer, T and Davidson, B and Teschendorff, A and Beck, S and Caplin, M (2010) Genome-Wide DNA Methylation Profiling of Pancreatic Neuroendocrine Tumors Identifies Distinct Methylation Profiles and Differentially Methylated Gene Promoter Regions Associated with Low, Medium and High Grade Tumors. In: NEUROENDOCRINOLOGY. (pp. 14 - 14). KARGER

Tolner, B and Vigor, K and Mather, S and Robinson, M and Adams, G and Plueckthun, A and Chester, K (2010) Anti-HER2 imaging agents for breast cancer imaging. In: BREAST CANCER RESEARCH. (pp. S13 - S13). BIOMED CENTRAL LTD

Tsochatzis, E and Garcovich, M and Marelli, L and Fede, G and Germani, G and Manousou, P and Arvaniti, V and Georgiadis, D and Burroughs, AK (2010) TRANSARTERIAL CHEMOEMBOLIZATION AS NEO-ADJUVANT THERAPY PRE-TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA. In: HEPATOLOGY. (pp. 858A - 859A). WILEY-BLACKWELL

Report

Pearce, S and Gibson, F and Fern, L and O'Hare, C and Taylor, R and Whelan, JS (2010) The 'Essence of care study' for teenagers and young adults with cancer: a national longitudinal study to assess the benefits of specialist care. Phase I: feasibility and scoping study.

This list was generated on Sat May 18 07:06:14 2013 BST.